Obtaining and research of pharmaceutical properties of antiemetics in a form of powder for inhalation
- 作者: Ivanov I.M.1, Pechurina T.B.1, Vengerovich N.G.1,2, Yudin M.A.1,3, Nikiforov A.S.1, Raguzin E.V.1, Kuzmich V.G.4, Proshina Y.A.1
-
隶属关系:
- State Scientific Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation
- Saint Petersburg State Chemical Pharmaceutical University of the Ministry of Health of the Russian Federation
- North-Western State Medical University named after I.I. Mechnikov of the Ministry of Health of the Russian Federation
- S.M. Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation
- 期: 卷 3, 编号 3 (2021)
- 页面: 24-31
- 栏目: Pharmaceutical Sciences
- URL: https://ogarev-online.ru/PharmForm/article/view/80634
- DOI: https://doi.org/10.17816/phf80634
- ID: 80634
如何引用文章
全文:
详细
Samples of antiemetic drugs (ondansetronum, palonosetronum, metoclopramidum) in the form of powder for inhalation have been developed by the method of spray drying. The granulometric composition, hygroscopicity and aerodynamic distribution of aerosol particles of the drugs have been investigated. The dosage form of the powder for inhalation of antiemetics (ondansetronum and palonosetronum) in terms of its particle size distribution, hygroscopicity and content of the agent corresponds to those for inhalation using dry powder inhalers. In the study of the phase-dispersed composition of aerosol, ondansetronum and palonosetronum in the dosage form of powder for inhalation as part of the HandiHaler inhaler (at a flow rate of 60 l/min) showed high rates of the released dose up to 72–76%, respirable particle fraction (up to 5 μm) up to 54–56% and a mass median particle size of about 3 microns. Obtaining the inhaled form of metoclopramide requires optimization of the production method for receiving the product with acceptable pharmaceutical properties.
作者简介
Igor Ivanov
State Scientific Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation
编辑信件的主要联系方式.
Email: gniiivm_15@mil.ru
SPIN 代码: 1518-3306
Ph.D. in Medicine, Head of the Research Department
俄罗斯联邦, 4 st. Lesoparkovaya, St. Petersburg, 195043Tatiana Pechurina
State Scientific Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation
Email: gniiivm_15@mil.ru
SPIN 代码: 7890-4203
Ph.D. in Technical Science, Researcher
俄罗斯联邦, 4 st. Lesoparkovaya, St. Petersburg, 195043Nikolai Vengerovich
State Scientific Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation; Saint Petersburg State Chemical Pharmaceutical University of the Ministry of Health of the Russian Federation
Email: nickolai.vengerovich@pharminnotech.com
ORCID iD: 0000-0003-3219-341X
SPIN 代码: 6690-9649
Scopus 作者 ID: 55639823300
Researcher ID: U-3467-2019
https://journals.eco-vector.com/PharmForm/about/editorialTeamBio/37267
Doctor of Medicine (MD), Deputy Head of the Research Department, Professor of the Industrial Ecology Department
俄罗斯联邦, 4 st. Lesoparkovaya, St. Petersburg, 195043; 14 lit. A st. Professor Popov, St. Petersburg, 197022Mikhail Yudin
State Scientific Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation; North-Western State Medical University named after I.I. Mechnikov of the Ministry of Health of the Russian Federation
Email: gniiivm_15@mil.ru
SPIN 代码: 4763-9666
Doctor of Medicine (MD), Associate Professor of the Toxicology and Experimental Medicine Department, Chief of the Research Department
俄罗斯联邦, 4 st. Lesoparkovaya, St. Petersburg, 195043; 41 Kirochnaya street, Saint-Petersburg, 191015Aleksandr Nikiforov
State Scientific Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation
Email: gniiivm_15@mil.ru
SPIN 代码: 3169-7701
D.Sc. in Biology, Leading Researcher
俄罗斯联邦, 4 st. Lesoparkovaya, St. Petersburg, 195043Evgenii Raguzin
State Scientific Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation
Email: gniiivm_15@mil.ru
SPIN 代码: 8524-3195
Ph.D. in Medicine, Deputy Head of the Research Department
俄罗斯联邦, 4 st. Lesoparkovaya, St. Petersburg, 195043Vladimir Kuzmich
S.M. Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation
Email: q-zmich1978@mail.ru
Ph.D. in Medicine, Associate Professor of the Military Field Therapy Department
俄罗斯联邦, 6G Akademika Lebedeva street, Saint-Petersburg, 194044Yulia Proshina
State Scientific Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation
Email: gniiivm_15@mil.ru
junior research fellow
俄罗斯联邦, 4 st. Lesoparkovaya, St. Petersburg, 195043参考
- Prikaz Ministerstva zdravoohraneniya RF ot 15.02.2013 № 70n «Ob utverzhdenii trebovanij k komplektacii lekarstvennymi preparatami i medicinskimi izdeliyami komplekta individual’nogo medicinskogo grazhdanskoj zashchity dlya okazaniya pervichnoj mediko-sanitarnoj pomoshchi i pervoj pomoshchi».
- Prikaz nachal’nika glavnogo voenno-medicinskogo upravleniya Ministerstva oborony Rossijskoj Federacii ot 12.07.2011 № 77 «Ob utverzhdenii sbornika opisej komplektov medicinskogo imushchestva dlya vojskovogo zvena medicinskoj sluzhby VS RF na voennoe vremya».
- Formulary of medicines of the medical service of the Armed Forces of the Russian Federation (fifth edition)/ ed. by A. Ya. Fisun and Yu. V. Miroshnichenko. – Moscow: GVKG im. N.N. Burdenko, 2014. – 178 p. (In Russ.)
- Ivchenko E. V. Results and prospects for improving the means and methods of medical protection from adverse factors of chemical nature / E. V. Ivchenko, A. A. Kuzmin, V. P. Fedonyuk [et al.] // Military Medical Journal. – 2019. – Vol. 340. – № 9. – P. 14–21. (In Russ.)
- Ivanov I. M. Prospects for the development of inhalation drugs for the provision of prehospital care to those affected by emergency hazardous chemicals / I. M. Ivanov, A. S. Nikiforov, M. A. Yudin [et al.] // Bulletin of the Russian Military Medical Academy. – 2020. – №3 (71). – P. 176–181. (In Russ.)
- Billio A., Morello E., Clarke M. J. Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. In: Billio A., editor. The Cochrane Database of Systematic Reviews. 2010 Jan; 1: CD006272. DOI:10.1002 / 14651858.CD006272.pub2.
- Inhaled Ondansetron & Dyspnea: clinical trials. U.S. National Library of Medicine [Internet]. 2013 [cited September 11, 2021]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT01851993.
- Ivanov I. M. Prospects for inhalation delivery of medical protective equipment for radiation injuries / I. M. Ivanov, A. S. Nikiforov, M. A. Yudin [et al.] // Radiation Biology. Radioecology. – 2020. – Vol. 60. – № 2. – P. 182–194. (In Russ.)
- Ivanov I. M. Prospects for the development of technical means and dosage forms for the use of medical protective equipment / I. M. Ivanov, S. V. Chepur, A. S. Nikiforov [et al.] // Military Medical Journal. – 2019. – Vol. CCCXL. – № 4.– P. 47–53. (In Russ.)
- Ivanov I. M. Justification of the requirements for promising technical means of inhalation delivery of drugs for use at the stages of medical evacuation / I. M. Ivanov, A. S. Nikiforov, S. V. Chepur [et al.] // Medline.ru. Russian Biomedical Journal. – 2019. – Vol. 20. – № 1. – P. 110–133. (In Russ.)
补充文件
